Modulatory effects of Pycnogenol® in a rat model of insulin-dependent diabetes mellitus: Biochemical, histological, and immunohistochemical evidences

Protoplasma

Volumn 250, Issue 1, 2013, Pages 347-360

  Parveen, Kehkashan ^a   Ishrat, Tauheed ^b   Malik, Shabnam ^a   Kausar, Mohd Adnan ^a   Siddiqui, Waseem A ^a  

^a HAMDARD UNIVERSITY   (India)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Liver; Oxidative stress; Pancreas; Pycnogenol; Streptozotocin; Type 1 diabetes

Indexed keywords

ANIMALIA; RATTUS;

EID: 84873088642     PISSN: 0033183X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00709-012-0418-2     Document Type: Article

References (57)

1. Baynes JW, Thrope SR (1999) Role of oxidative stress in diabetic complications. Diabetes 48: 1-9.
2. Claiborne A (1985) Catalase activity. In: Green Wald RA (ed) CRC handbook of methods for oxygen radical research. CRC Press, Boca Raton, pp 283-284.
3. Cortas N, Wakid N (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36: 1440-1443.
4. Elgawish A, Glomb M, Freelander M, Monnier VM (1996) Involvement of hydrogen peroxide in collagen cross-linking by high glucose in vitro and in vivo. J Biol Chem 271: 12964-12971.
5. Ferre T, Pujol A, Riu E, Bosch F, Valera A (1996) Correction of diabetic alterations by glucokinase. Proc Nat Acad Sci 93: 7225-7230.
6. Fujimoto M, Shimizu N, Kunii K, Martyn JA, Ueki K, Kaneki M (2005) A role for iNOS in fasting hyperglycemia and impaired insulin signaling in the liver of obese diabetic mice. Diabetes 54: 1340-1348.
7. Fukuda K, Akao S, Ohno Y, Yamashita K, Fujiwara H (2001) Inhibition by costunolide of phorbol ester-induced transcriptional activation of inducible nitric oxidesynthase gene in a human monocyte cell line THP-1. Cancer Lett 1: 7-13.
8. Grimm T, Skrabala R, Chovanova Z et al (2006) Single and multiple dose pharmacokinetics of maritime pine bark extract (Pycnogenol) after oral administration to healthy volunteers. BMC Clin Pharmacol 6: 4.
9. Gunawardana SC, Steven Head W, Piston DW (2008) Dimethyl amiloride improves glucose homeostasis in mouse models of type 2 diabetes. Am J Physiol Endocrinol Metab 294: 1097-1108.
10. Habig WH, Pabst M, Jakoby WB (1974) Glutathione-S-transferase. The first enzymatic step in mercapturic acid formation. J Biol Chem 249: 7130-7139.
11. Halliwell B, Gutteridge J (1989) Free radicals in biology and medicine. Oxford University Press, New York.
12. Hamden K, Carreau S, Lajmi S, Aloulou D, kchaou D, Elfeki A (2008) Hyperglycaemia, stress oxidant, liver dysfunction and histological changes in diabetic male rat pancreas and liver: Protective effect of 17β-estradiol. Steroids 94: 495-501.
13. Hardt PD, Krauss A, Bretz L et al (2000) Pancreatic exocrine function in patients with type 1 and type 2 diabetes mellitus. Acta Diabetol 37: 105-110.
14. Hellestrom C (1997) Growth pattern of pancreatic islets in animals. In: Volk BV, Wellman KE (eds) The diabetic pancreas, 1st edn. Plenum Medical Book Co, New York, pp 61-97.
15. Ihara Y, Toyokuni S, Uchida K, Odaka H, Tanaka T et al (1999) Hyperglycemia causes oxidative stress in pancreatic beta cells of GK rats, a model of type 2 diabetes. Diabetes 48: 927-932.
16. Jankyova S, Kucera P, Goldenberg Z et al (2009) Pycnogenol efficiency on glycaemia, motor nerve conduction velocity and markers of oxidative stress in mild type diabetes in rats. Phytother Res 23: 1169-1174.
17. Johansen JS, Alex KH, David JR, Adviye E (2005) Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovas Diabetol 4: 5.
18. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR (1974) Bromobenzene-induced liver necrosis: protective role of glutathione and evidence for 3, 4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacol 11: 151-169.
19. Kamiya K, Hamabe W, Harada S, Murakami R, Tokuyama S, Satake T (2008) Chemical constituents of orinda citrifolia roots exhibit hypoglycemic effects in streptozotocin-induced diabetic mice. Biol Pharm Bull 31: 935-938.
20. Kim MGRG, Chung JS, Sim SS et al (2003) Protective effects of epicatechin against the toxic effects of streptozotocin on rat pancreatic islets: in vivo and in vitro. Pancreas 26: 292-299.
21. Kobuchi H, Virgili F, Packer L (1999) Assay of inducible form of nitric oxide synthase activity: effect of flavonoids and plant extracts. Methods Enzymol 301: 504-513.
22. Korc M, Owerbach D, Quinto C, Rutter WJ (1981) Pancreatic islet-acinar cell interaction: amylase messenger RNA levels are determined by insulin. Sci 213: 351-353.
23. Lechleitner M, Koch T, Herold M, Hoppichler F (1999) Relationship of tumor necrosis factor-alpha plasma levels to metabolic control in type 1 diabetes. Diabetes Care 22: 1749.
24. Leclercq B, Jaimes EA, Raij L (2002) Nitric oxide synthase and hypertension. Curr Opin Nephrol Hyperten 11: 185-189.
25. Lee HH, Kim KJ, Yoon KY, Lee BY (2008) Effect of Pycnogenol on glucose transporter 4 expression and glucose uptake stimulatory activity in 3 t3-L1 adipocytes. FASEB J 24: 1242-1249.
26. Lernmark A (2000) Rapid-onset type 1 diabetes with pancreatic exocrine dysfunction. N Eng J Med 342: 344-345.
27. Levine RL, Garland D, Oliver CN et al (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186: 464-478.
28. Liu X, Wei J, Tan F, Zhou S, Würthwein G, Rohdewald P (2004a) Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II. Life Sci 75: 2505-2513.
29. Liu X, Zhou HJ, Rohdewald P (2004b) French maritime pine bark extract Pycnogenol dose-dependently lowers glucose in type 2 diabetic patients. Diabetes Care 27: 839.
30. Lolitkar MM, Rao RR (1966) Pharmacology of hypoglycemic principle isolated from the fruits of M. charantia Linn. Ind J Pharm 28: 129-133.
31. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
32. Mandrup-Poulsen T, Helqvist S, Wogensen LD et al (1990) Cytokines and free radicals as effector molecules in the destruction of pancreatic beta cells. Curr Top Microbiol Immunol 164: 169-193.
33. Maritim A, Dene BA, Sanders RA, Watkins JB III (2003) Effects of Pycnogenol treatment on oxidative stress in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 17: 193-199.
34. Mohamed AK, Bierhaus A, Schiekofer S, Tritschler H, Ziegler R, Nawroth PP (1999) The role of oxidative stress and NF-B activation in late diabetic complications. Biofactors 10: 157-167.
35. Moini H, Guo Q, Packer L (2000) Enzyme inhibition and protein-binding action of the procyanidin-rich French maritime pine bark extract, pycnogenol: effect on xanthine oxidase. J Agric Food Chem 48: 5630-5639.
36. Nardini M, Scaccini C, Packer L, Virgili F (2000) In vitro inhibition of the activity of phosphorylase kinase, protein kinase C and protein kinase A by caffeic acid and a procyanidin-rich pine bark (Pinus marittima) extract. Biochim et Biophysic Acta 1474: 219-225.
37. Nelson AB, Lau BHS, Ide N, Rong Y (1998) Pycnogenol inhibits macrophage oxidative burst, lipoprotein oxidation, and hydroxyl radical-induced DNA damage. Drug Dev Indust Pharm 24: 139-144.
38. Packer L, Rimbach G, Virgili F (1999) Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic Biol Med 27: 704-724.
39. Pari L, Murugan P (2005) Effect of tetrahydrocurcumin on blood glucose, plasma insulin and hepatic key enzymes in streptozotocin induced diabetic rats. J Basic & Clin Physiol Pharmacol 16: 257-274.
40. Parveen K, Khan MR, Siddiqui WA (2009) Pycnogenol® prevents potassium dichromate (K2Cr2O7)-induced oxidative damage and nephrotoxicity in rats. Chem-Biol Interact 181: 343-350.
41. Parveen K, Khan MR, Mujeeb M, Siddiqui WA (2010) Protective effects of Pycnogenol® on hyperglycemia-induced oxidative damage in the liver of type 2 diabetic rats. Chem-Biol Interact 186: 219-27.
42. Rajasekaran S, Sivagnanam K, Subramanian S (2005) Antioxidant effect of Aloe vera gel extract in streptozotocin-induced diabetes in rats. Pharmacol Rep 57: 90-96.
43. Rohdewald P (2002) A review of the French maritime pine bark extract (Pycnogenol), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Therap 40: 158-168.
44. Rohdewald P (2005) Pycnogenol, French maritime pine bark extract. In: Coates PM, BlackMan MR, Cragg G, Levine M, Moss J, White J (eds) Encyclopedia of dietary supplements. Marcel Dekker, New York, pp 545-53.
45. Sabu MC, Kuttan R (2002) Anti-diabetic activity of medicinal plants and its relationship with their antioxidant property. J Ethnopharmacol 81: 155-160.
46. Sarika Jain P, Pandhi APS, Malhotra S (2006) Efficacy of standardised herbal extracts in type 1 diabetes-an experimental study. Afr J Trad CAM 3: 23-33.
47. Schafer A, Hogger P (2007) Oligomeric procyanidins of French maritime pine bark extract (Pycnogenol) effectively inhibit alpha-glucosidase. Diabetes Res Clin Prac 77: 41-46.
48. Schreck R, Albermann K, Baeuerle PA (1992) Nuclear factor kappa B: an oxidative stress responsive transcription factor of eukaryotic cells. Free Radic Res Comm 17: 221-237.
49. Seifter S, Dayton S, Noyic B, Muntwyler E (1950) Estimation of glycogen with anthrone reagent. Arch Biochem 25: 191.
50. Shimizu M, Kobayashi Y, Suzuki M, Satsu H, Miyamoto Y (2000) Regulation of intestinal glucose transport by tea catechins. Biofactors 13: 61-65.
51. Suresh Babu P, Srinivasan K (1998) Amelioration of renal lesions associated with diabetes by dietary curcumin in streptozotocin diabetic rats. Mol Cell Biochem 181: 87-96.
52. Surh YJ, Chun KS, Cha HH, Han SS, Keum YS, Park KK, Lee SS (2001) Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-k{cyrillic}B activation. Mutat Res 480-481: 243-268.
53. Utley HC, Bernheim F, Hochslein P (1967) Effect of sulfhydryl reagent on peroxidation in microsome. Arch Biochem Biophysics 118: 29-32.
54. Vessby J, Basu S, Mohsen R, Berne C, Vessby B (2002) Oxidative stress and antioxidant status in type 1 diabetes mellitus. J Intern Med 251: 69-76.
55. Wei ZH, Peng QL, Lau BHS (1997) Pycnogenol enhances endothelial cell antioxidant defenses. Redox Rep 3: 219-224.
56. Wolff SP (1993) Diabetes mellitus and free radicals. Br Med Bul 49: 642-652.
57. Zibadi S, Rohdewald PJ, Park D, Watson RR (2008) Reduction of cardiovascular risk factors in subjects with type 2 diabetes by Pycnogenol supplementation. Nutr Res 28: 315-320.